Zhejiang Xianju Pharmaceutical Co.,Ltd.

Shenzhen Stock Exchange 002332.SZ

Zhejiang Xianju Pharmaceutical Co.,Ltd. EPS (Diluted) for the year ending December 31, 2023: USD 0.08

Zhejiang Xianju Pharmaceutical Co.,Ltd. EPS (Diluted) is USD 0.08 for the year ending December 31, 2023, a -27.10% change year over year. EPS (Diluted) reflects the company's earnings per share adjusted for the potential dilution that could occur if all convertible securities were converted to common stock, providing a more conservative profitability measure.
  • Zhejiang Xianju Pharmaceutical Co.,Ltd. EPS (Diluted) for the year ending December 31, 2022 was USD 0.11, a 11.08% change year over year.
  • Zhejiang Xianju Pharmaceutical Co.,Ltd. EPS (Diluted) for the year ending December 31, 2021 was USD 0.10, a 26.90% change year over year.
  • Zhejiang Xianju Pharmaceutical Co.,Ltd. EPS (Diluted) for the year ending December 31, 2020 was USD 0.08, a 20.91% change year over year.
  • Zhejiang Xianju Pharmaceutical Co.,Ltd. EPS (Diluted) for the year ending December 31, 2019 was USD 0.06, a 34.68% change year over year.
Key data
Date EPS (Diluted) Shares (Diluted, Weighted) Shares (Basic, Weighted) Revenue
Market news
Loading...
SV Wall Street
Shenzhen Stock Exchange: 002332.SZ

Zhejiang Xianju Pharmaceutical Co.,Ltd.

Description

Zhejiang Xianju Pharmaceutical Co.,Ltd. manufactures and sells steroids and hormones worldwide. The company offers active pharmaceutical ingredients, such as steroid drugs, and male and female hormones; intermediates; and finished formulations in the form of tablets, capsules, granules, soft capsules, powder inhalations, creams, gels, injections, and powder-injections. Zhejiang Xianju Pharmaceutical Co.,Ltd. was founded in 1972 and is based in Xianju, China.

Similar companies

002317.SZ

Guangdong Zhongsheng Pharmaceutical Co., Ltd.

USD 1.46

-4.33%

002390.SZ

Guizhou Xinbang Pharmaceutical Co., Ltd.

USD 0.54

-5.84%

002294.SZ

Shenzhen Salubris Pharmaceuticals Co., Ltd.

USD 4.11

-0.16%

StockViz Staff

February 3, 2025

Any question? Send us an email